We are live on ! Find out more
ACP

Ashfield Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 14.56%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
AUM
$2.07B
AUM Growth
+$12.9M
Cap. Flow
-$63.8M
Cap. Flow %
-3.08%
Top 10 Hldgs %
26.25%
Holding
286
New
8
Increased
64
Reduced
113
Closed
20

Top Buys

Rank Stock Value
1
HDS
HD Supply Holdings, Inc.
HDS
+$29.2M
2
NVS icon
Novartis
NVS
+$27.6M
3
SHPG
Shire pic
SHPG
+$25.6M
4
MSFT icon
Microsoft
MSFT
+$22.3M
5
COST icon
Costco
COST
+$14.6M

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Healthcare 17.6%
3 Consumer Discretionary 12.61%
4 Industrials 12.57%
5 Financials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$91.6M 4.43%
3,320,688
-39,832
-1% -$1.08M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.91T
$69.6M 3.36%
2,640,389
-44,643
-2% -$1.2M
V icon
3
Visa
V
$666B
$56.4M 2.73%
860,552
-22,336
-3% -$1.34M
UNP icon
4
Union Pacific
UNP
$181B
$54.4M 2.63%
456,346
-8,925
-2% -$1.02M
AMP icon
5
Ameriprise Financial
AMP
$46.8B
$50.3M 2.43%
380,361
-10,145
-3% -$1.28M
CELG
6
DELISTED
Celgene Corp
CELG
$50.2M 2.43%
448,920
-11,095
-2% -$1.17M
VFC icon
7
VF Corp
VFC
$6.52B
$45.6M 2.2%
646,367
-13,433
-2% -$889K
BLK icon
8
Blackrock
BLK
$162B
$44.2M 2.14%
123,669
-2,907
-2% -$993K
HAIN icon
9
Hain Celestial
HAIN
$48.8M
$40.8M 1.97%
700,426
-16,582
-2% -$897K
CERN
10
DELISTED
Cerner Corp
CERN
$40.1M 1.94%
620,455
-15,807
-2% -$983K
BIIB icon
11
Biogen
BIIB
$29.9B
$39.1M 1.89%
115,129
+19,980
+21% +$6.46M
ADI icon
12
Analog Devices
ADI
$184B
$37.6M 1.82%
678,071
+199,477
+42% +$10.2M
BWA icon
13
BorgWarner
BWA
$13.1B
$37.2M 1.8%
768,646
-22,912
-3% -$1.12M
COST icon
14
Costco
COST
$408B
$35.2M 1.7%
248,453
+107,069
+76% +$14.6M
TMO icon
15
Thermo Fisher Scientific
TMO
$214B
$34.2M 1.65%
272,647
-4,891
-2% -$595K
ADBE icon
16
Adobe
ADBE
$84.7B
$33.9M 1.64%
466,867
-19,517
-4% -$1.37M
DHR icon
17
Danaher
DHR
$133B
$33.6M 1.62%
583,293
-14,186
-2% -$769K
SLB icon
18
SLB Ltd
SLB
$71.4B
$33.4M 1.62%
391,369
-10,241
-3% -$942K
APC
19
DELISTED
Anadarko Petroleum
APC
$33.3M 1.61%
403,939
+136,618
+51% +$11.9M
RTX icon
20
RTX Corp
RTX
$284B
$32.2M 1.56%
445,162
-17,115
-4% -$1.17M
SBUX icon
21
Starbucks
SBUX
$117B
$31.3M 1.51%
762,968
-18,138
-2% -$708K
URI icon
22
United Rentals
URI
$72.5B
$30.8M 1.49%
302,387
-6,339
-2% -$679K
MSFT icon
23
Microsoft
MSFT
$2.82T
$30.8M 1.49%
663,491
+476,120
+254% +$22.3M
HDS
24
DELISTED
HD Supply Holdings, Inc.
HDS
$30.6M 1.48%
+1,039,351
New +$29.2M
NVS icon
25
Novartis
NVS
$297B
$30.1M 1.45%
362,645
+333,186
+1,131% +$27.6M

Similar funds

Ashfield Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Ashfield Capital Partners held 286 positions worth $2.07B, up 0.62% from $2.06B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ashfield Capital Partners withdrew a net $63.8M in Q4 2014, closing 20 positions and reducing 113 holdings. Its most notable exit was Urban Outfitters, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ashfield Capital Partners opened a new position in HD Supply Holdings, Inc. worth $30.6M.

  • Ashfield Capital Partners's largest Q4 2014 buy was HD Supply Holdings, Inc.: 1,039,351 shares worth $30.6M.
  • Ashfield Capital Partners added most to Novartis in Q4 2014, an estimated $27.6M increase.
  • Ashfield Capital Partners's biggest Q4 2014 reduction was Bausch Health, cutting an estimated $32.6M.
  • Ashfield Capital Partners fully exited Urban Outfitters in Q4 2014, selling an estimated $19.5M.
  • Ashfield Capital Partners's ten largest holdings make up 26% of its $2.07B portfolio in Q4 2014.
  • Ashfield Capital Partners opened 8 new positions and closed 20 in Q4 2014.
  • Ashfield Capital Partners's portfolio value rose 0.62% quarter-over-quarter to $2.07B.

Based on Ashfield Capital Partners's 13F filing for Q4 2014, filed 13 Feb 2015.